1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Gliptins

Gliptins

46 - 60 of 67 Results
Sort Results:
Guideline: Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013) June 2013
Article: a new diabetes drug, Invokana (in-vo-KAHN-uh, canagliflozin) hit your pharmacy shelves May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis April 2013
Chart: Drug-Induced Pancreatitis April 2013
Article: how to manage diabetes during an acute illness March 2013
Commentary: Sick Day Management of Diabetes March 2013
Patient Education: How to Manage Sick Days with Diabetes March 2013
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
Commentary: Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes August 2012
Article: patients getting combinations of certain diabetes meds...Byetta with Januvia, Victoza with Onglyza, etc August 2012
Article: more emphasis on the prevention and treatment of type 2 diabetes in CHILDREN July 2012
Guideline: Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada July 2012
Article: new combo drug, Juvisync (JU-vih-sink), for treating diabetes November 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011